Vera Therapeutics, Inc. (VERA)
Nasdaq: VERA · Pharmaceutical Preparations · Brisbane, CA · filing with the SEC since 2021
Who runs Vera Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Fordyce Marshall
PRESIDENT AND CEO. First filing May 2021, latest Sep 17, 2026, 30 filings in all.
Officers reporting now
10
of 19 people with a filing in the last fifteen months
Directors reporting now
9
24 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Fordyce Marshall | PRESIDENT AND CEO | May 2021 | Sep 17, 2026 | 22 · $9.7M |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | May 2021 | Sep 14, 2026 | 2 · $600,000 |
| Boman Nancy Lee | Chief Regulatory Officer | Aug 2026 | Aug 5, 2026 | none |
| Wright-Mitchell Jane | Chief Legal Officer | Mar 2026 | Mar 25, 2026 | none |
| Grant Sean | CHIEF FINANCIAL OFFICER | Jul 2021 | Feb 25, 2026 | 1 · $200,000 |
| Johnson David Lee | Chief Operating Officer | Jul 2024 | Feb 25, 2026 | 1 · $100,000 |
| Brenner Robert | Chief Medical Officer | Jan 2024 | Feb 25, 2026 | 1 · $100,000 |
| Skelton Laurence Matthew | Chief Commercial Officer | Jan 2026 | Feb 25, 2026 | 1 · $100,000 |
| Turner William D. | Chief Regulatory Officer | Jan 2024 | Feb 25, 2026 | 4 · $1.4M |
| Carter Jason S | Chief Legal Officer | Nov 2024 | Nov 25, 2025 | 1 · $100,000 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cheng Andrew | director | May 2021 | May 26, 2026 | none |
| Enright Patrick G | director | May 2021 | May 26, 2026 | none |
| Hall Kimball | director | Dec 2021 | May 26, 2026 | none |
| Meyers James R | director | Nov 2025 | May 26, 2026 | none |
| Morrison Scott W | director | May 2021 | May 26, 2026 | none |
| Morrissey Michael | director | May 2022 | May 26, 2026 | none |
| Oliger Christy J. | director | Jun 2024 | May 26, 2026 | none |
| Seidenberg Beth C | director | May 2021 | May 26, 2026 | none |
| Hite Christopher | director | Mar 2026 | Mar 9, 2026 | none |
Earlier names on the record25, newest filing first
Katabi Maha · director · last filing May 2025Commodore Capital LP · 10% owner · last filing Jan 2024Curley Joanne · officer · last filing Aug 2023Lin Celia · officer · last filing Aug 2023Healy James · 10% owner · last filing Feb 2023Longitude Capital Partners IV, LLC · 10% owner · last filing Feb 2023Longitude Prime Fund, L.P. · 10% owner · last filing Feb 2023Longitude Prime Partners, LLC · 10% owner · last filing Feb 2023Longitude Venture Partners IV, L.P. · 10% owner · last filing Feb 2023Sofinnova Management X-A, L.L.C. · 10% owner · last filing Feb 2023Sofinnova Management X, L.L.C. · 10% owner · last filing Feb 2023Sofinnova Venture Partners X, L.P. · 10% owner · last filing Feb 2023Tammenoms Bakker Juliet · 10% owner · last filing Feb 2023Abingworth Bioventures 8 LP · 10% owner · last filing Aug 2022Abingworth Llp · 10% owner · last filing Aug 2022Carlyle Genesis Uk LLC · 10% owner · last filing Aug 2022Carlyle Group Inc. · 10% owner · last filing Aug 2022Carlyle Holdings I Gp Inc. · 10% owner · last filing Aug 2022Carlyle Holdings I Gp Sub L.L.C. · 10% owner · last filing Aug 2022Carlyle Holdings I L.P. · 10% owner · last filing Aug 2022Carlyle Investment Management LLC · 10% owner · last filing Aug 2022Cg Subsidiary Holdings L.L.C. · 10% owner · last filing Aug 2022Tc Group, LLC · 10% owner · last filing Aug 2022Emster Kurt Von · director · last filing May 2021Wolter Jonathan · officer · last filing May 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.